Back
Vistagen Therapeutics 10K Form
Sell
41
VTGN
Vistagen Therapeutics
Last Price:
4.47
Seasonality Move:
5.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VTGN News And Ratings
See the #1 stock for the next 7 days that we like better than VTGN
VTGN Financial Statistics
Sales & Book Value
| Annual Sales: | $-227.3K |
|---|---|
| Cash Flow: | $-4.57M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.56 |
| Price / Book: | 0.97 |
Profitability
| EPS (TTM): | -3.50910 |
|---|---|
| Net Income (TTM): | $-32.07M |
| Gross Margin: | $0 |
| Return on Equity: | -80.76% |
| Return on Assets: | -67.06% |
Vistagen Therapeutics Earnings Forecast
Key Vistagen Therapeutics Financial Ratios
- The Interest Expense is -0.04% of Operating Income.
- Per Share Earnings over the last 15 years have been positive in 7 years.
Vistagen Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VTGN |
| CUSIP: | 92840H |
| Website: | vistagen.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 30.76 |
| Quick Ratio: | 30.39 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VTGN Technical Analysis vs Fundamental Analysis
Sell
41
Vistagen Therapeutics (VTGN)
is a Sell
Is Vistagen Therapeutics a Buy or a Sell?
-
Vistagen Therapeutics stock is rated a Sell
The current Vistagen Therapeutics [VTGN] share price is $4.44. The Score for VTGN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.